|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Multiple Sclerosis Info
Favorite Links
This Month
Month Archive
|
Saturday, April 12
MS Therapies - Rebif
by
multiplesclerosis
on Sat 12 Apr 2008 03:00 PM CST
Interferon beta-1a belongs to the group of medications known as immunomodulators. Interferon is a substance that is naturally made by our body's cells to fight infections and tumours. Many diseases such as multiple sclerosis and more »
Wednesday, March 19
Rash from interferon beta 1-a (Rebif or Betaseron)
by
multiplesclerosis
on Wed 19 Mar 2008 02:00 AM CST
We describe a 41-year-old woman with multiple sclerosis, who presented with redness of the skin; several discoloured areas; along with inflammatory small, more »
Tuesday, March 4
Merck Serono Launches New Formulation Of Interferon Beta-1a
by
multiplesclerosis
on Tue 04 Mar 2008 08:21 AM CST
Merck Serono, a division of Merck KGaA, has announced that Rebif® New Formulation (interferon beta-1a) will be available in the UK. In a recent two-year (96 week) Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold more »
Tuesday, February 26
Predictive markers for response to interferon therapy in patients with multiple sclerosis.
by
multiplesclerosis
on Tue 26 Feb 2008 12:00 AM CST
Prolonged therapy with interferon beta (IFNbeta) often leads to the development of anti-IFNbeta binding antibodies (BAbs). A subset of the BAbs is of a neutralizing nature (neutralizing antibodies, NAbs) and more »
Monday, December 31
Rebif & Influenza Vaccine
by
multiplesclerosis
on Mon 31 Dec 2007 09:46 AM CST
"Immune Response to Influenza Vaccine is Maintained in MS Patients Treated With Rebif (interferon beta-1a)" November 10, 2005 – Data presented at: XVIIIth World Congress of Neurology in ... more » Wednesday, November 28
New natural history of interferon-beta-treated RRMS
by
multiplesclerosis
on Wed 28 Nov 2007 12:00 AM CST
New natural history of interferon-beta-treated relapsing multiple sclerosis. Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy. To investigate the impact ... more » Saturday, April 15
New Rebif® Formulation Submitted In USA And Europe
by
multiplesclerosis
on Sat 15 Apr 2006 12:00 AM CST
Serono (virt-x:SEO and NYSE: SRA) announced today the submission of a supplemental Biologics Licence Application (sBLA) to the US Food and Drug Administration (FDA) and of a variation to the current Marketing Authorization to the European Medicines Agency (EMEA) for a new formulation of Rebif® (interferon beta-1a) as a treatment of multiple sclerosis (MS).
Data from a Phase III clinical trial in patients with more »
Sunday, January 8
Rebif (Interferon beta-1a)
by
multiplesclerosis
on Sun 08 Jan 2006 12:00 AM CST
Rebif (Interferon beta-1a)Rebif (Interferon beta-1a) is a genetically modified beta interferon produced in mammalian cells. Along with Avonex (Interferon beta-1a) , Avonex (approved 2002 U.S FDA) is one ... more » |
||||||||||||||||||||||||||||||||||||||||||||||
